Preoperative statin use and outcomes following cardiac surgery

International Journal of Cardiology

Volumn 103, Issue 1, 2005, Pages 12-18

  Ali, Imtiaz S ^a   Buth, Karen J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cardiac surgery; Perioperative myocardial infarction; Statin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; AORTA BALLOON; ARTICLE; ARTIFICIAL VENTILATION; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS GRAFT; DRUG USE; FEMALE; HEART INFARCTION; HEART SURGERY; HEART VALVE SURGERY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PERIOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL MODEL; STROKE; TREATMENT OUTCOME;

AGED; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERIOSCLEROSIS; FEMALE; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 23044467734     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.06.006     Document Type: Article

References (27)

1. S.M. Grundy HMG-CoA reductase inhibitors for treatment of hypercholesterolemia N. Engl. J. Med. 319 1998 24 33
2. D.J. Maron, S. Fazio, and M.F. Linton Current perspectives on statins Circulation 101 2000 207 213
3. Scandinavian Simvastatin Survival Study Group Randomized trial of cholesterol lowering in 4444 patients with coronary artery disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
4. Heart Protection Study Collaboration Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial Lancet 360 2002 7 22
5. Z.A. Massy, W.F. Keane, and B.L. Kasiske Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? Lancet 347 1996 102 103
6. S. Wolfrum, K.S. Jensen, and J.K. Liao Endothelium-dependent effects of statins Arterioscler Thromb. Vasc. Biol. 23 2003 729 736
7. A.C. Sposito, and M.J. Chapman Statin therapy in acute coronary syndromes. Mechanistic insight into clinical benefit Arterioscler Thromb. Vasc. Biol. 22 2002 1524 1534
8. V. Birjiniuk Patient outcomes in the assessment of myocardial injury following cardiac surgery Ann. Thorac. Surg. 72 2001 S2208 S2213
9. P.D. Napoli, A.A. Taccardi, A. Grilli, R. Spina, M. Felaco, and A. Barsotti Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts Cardiovasc. Res. 51 2001 283 293
10. H.L. Lazar, Y. Bao, Y. Zhang, and S.A. Bernard Pretreatment with statins enhances myocardial protection during coronary revascularization J. Thorac. Cardiovasc Surg. 125 2003 1037 1042
11. S.P. Jones, M.F. Gibson, D.M. Rimmer III, T.M. Gibson, B.R. Sharp, and D.J. Lefer Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor J. Am. Coll Cardiol. 40 2002 1172 1178
12. S. Wassmann, A. Faul, B. Hennen, B. Schaeller, M. Bohm, and G. Nickenig Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on coronary endothelial function Circ. Res. 93 2003 e98 e103
13. D. Poldermans, J.J. Bax, M.D. Kertai, B. Krennig, C.M. Westerhout, and A.F.L. Schinkel Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery Circulation 107 2003 1848 1851
14. The Post Coronary Artery Bypass Trial Investigators The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts N. Engl. J. Med. 336 1997 153 162
15. C.W. White, F.L. Gobel, L. Campeau, G.L. Knatterud, S.A. Forman, and J.S. Forrester Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial Circulation 104 2001 2660 2665
16. R. Scalia, and T.J. Stalker Microcirculation as a target for the anti-inflammatory properties of statins Microcirculation 9 2002 431 442
17. R.S. Rosenson, and A.S. Brown Statin use in acute coronary syndromes: cellular mechanisms and clinical relevance Curr. Opin. Lipidol. 13 2002 625 630
18. J. Hermann, A. Lerman, D. Baumgart, L. Volbracht, R. Schulz, and C. von Birgelen Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction Circulation 106 2002 2180 2183
19. A.W. Chan, D.L. Bhatt, D.P. Chew, M.J. Quinn, D.J. Moliterno, and E.J. Topol Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention Circulation 105 2002 691 696
20. A.W. Chan, D.L. Bhatt, D.P. Chew, J. Reginelli, J.P. Schneider, and E.J. Topol Relation of inflammation and benefit of statins after percutaneous coronary interventions Circulation 107 2003 1750 1756
21. S. Gelman The pathophysiology of aortic cross-clamping and unclamping Anesthesiology 82 1995 1026 1060
22. E.D. Verrier, and E.N. Morgan Endothelial response to cardiopulmonary bypass Ann. Thorac. Surg. 66 1998 S17 S19
23. S.P. Jones, S.D. Trocha, and D.J. Lefer Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion Arterioscler Thromb. Vasc. Biol. 21 2001 2059 2064
24. R.M. Bell, and D.M. Yellon Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway J. Am. Coll. Cardiol. 41 2003 508 515
25. I.M. Dotani, D.M. Elnicki, A.C. Jain, and C.M. Gibson Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting Am. J. Cardiol. 86 2000 1128 1130
26. E. Florens, S. Salvi, J. Peynet, C. Elbim, Z. Mallat, and A. Bel Can statins reduce the inflammatory response to cardiopulmonary bypass? A clinical study J. Card. Surg. 16 2001 232 239
27. S.V. Rendig, J.D. Symons, and E.A. Amsterdam Effects of statins on myocardial and coronary artery response to ischemia-reperfusion Can. J. Physiol. Pharmacol. 81 2003 1064 1071